These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 364647)

  • 1. Prevention of deep vein thrombosis by subcutaneous ancrod.
    Lowe GD
    Scott Med J; 1978 Oct; 23(4):329-30. PubMed ID: 364647
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery.
    Belch JJ; Meek DR; Lowe GD; Campbell AF; Young AB; Forbes CD; Prentice CR
    Thromb Res; 1982 Jan 1-15; 25(1-2):23-31. PubMed ID: 7038977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur.
    Lowe GD; Campbell AF; Meek DR; Forbes CD; Prentice CR
    Lancet; 1978 Sep; 2(8092 Pt 1):698-700. PubMed ID: 80632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thrombosis.
    Forbes CD; MacKay N
    Scott Med J; 1978 Oct; 23(4):261-2. PubMed ID: 725578
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous ancrod in prevention of deep-vein thrombosis.
    Lowe GD; Campbell AF; Meek DR; Forbes CD; Prentice CR
    Lancet; 1979 Jan; 1(8106):51-2. PubMed ID: 83504
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
    Lowe GD; Morrice JJ; Fulton A; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1978 Aug; 40(1):134-43. PubMed ID: 725844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femur.
    Barrie WW; Wood EH; Crumlish P; Forbes CD; Prentice CR
    Br Med J; 1974 Oct; 4(5937):130-3. PubMed ID: 4607845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 10. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspects of defibrinogenation therapy].
    Klüken N
    Phlebologie; 1975; 28(1):39-41. PubMed ID: 1202532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.
    Spiekermann BF; Lake CL; Rich GF; Humphries JE
    Anesthesiology; 1994 Mar; 80(3):686-8. PubMed ID: 8141466
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 14. Small subcutaneous doses of heparin in prevention of venous thrombosis.
    Gallus AS; Hirsh J; Tutle RJ; Trebilcock R; O'Brien SE; Carroll JJ; Minden JH; Hudecki SM
    N Engl J Med; 1973 Mar; 288(11):545-51. PubMed ID: 4568221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep-vein thrombosis in patients with fractured neck of femur.
    Field ES; Kakkar VV; Nicolaides AN; Renney JT
    Br J Surg; 1971 Nov; 58(11):873. PubMed ID: 5124911
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of early thrombosis prophylaxis following fracture of the femoral neck. A comparison between dextran and dicoumarol.
    Bergquist E; Bergqvist D; Bronge A; Dahlgren S; Lindquist B
    Acta Chir Scand; 1972; 138(7):689-93. PubMed ID: 4118601
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological prophylaxis of venous thrombo-embolism.
    Flute PT
    S Afr Med J; 1976 Feb; 50(6):165-9. PubMed ID: 1257852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.